In breast cancer, HDAC6 was frequently upregulated in the cancer-associated fibroblasts(CAFs) and increased the expression of COX-2/PGE2 by regulating STAT3 activation (20), leading to poor survival outcomes. Here, PTGS2 is linked to breast cancer.